Skip to main content
Clinical Trials/IRCT20190402043157N1
IRCT20190402043157N1
Completed
Phase 1

The effect of combined oral supplementation vitamin D, zinc, calcium and magnesium on glycemic control, lipid profiles, liver enzymes and CRP index in Type 2 diabetic patients

Oroumia University of Medical Sciences0 sites78 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Diabetes.
Sponsor
Oroumia University of Medical Sciences
Enrollment
78
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Adults (18 years of age and under 65 years of age)
  • People with type 2 diabetes who use the same drug (metformin, glibenclamide, metformin\-repaglinide).

Exclusion Criteria

  • Pregnant and lactating people
  • People who are going to have a pregnancy
  • Smoking and alcohol
  • People with polycystic ovary syndrome (if accompanied by type 2 diabetes insulin resistance)
  • Having any underlying heart disease and cancer
  • Species that have kidney, liver and chronic diseases or acute inflammation (especially acute pancreatic inflammation) and thyroid gland diseases
  • Cystic fibrosis (malabsorption)
  • People with gastrointestinal diseases (celiac disease, Crohn's disease, peptic ulcer, diverticulosis, IBD, IBS)
  • People undergoing gastric bypass surgery (malabsorption)
  • People undergoing cholecystectomy (malabsorption)

Outcomes

Primary Outcomes

Not specified

Similar Trials